logo
Biocon raises ₹4,500 crore through QIP

Biocon raises ₹4,500 crore through QIP

The Hindu20-06-2025
Biocon said it completed its Qualified Institutions Placement (QIP) and raised ₹4,500 crore through the issuance of 13,63,63,635 equity shares of face value ₹5 each to eligible qualified institutional buyers at the issue price of ₹330 per equity share (including a premium of ₹325 per equity share).
The QIP, which opened on June 16 and closed on June 19, witnessed robust investor interest from a diverse group of domestic and international investors, underscoring strong confidence in Biocon's growth prospects, said the company on Friday.
Siddharth Mittal, CEO and Managing Director, Biocon Limited, said, 'The strong response to our QIP reflects deep investor conviction in Biocon's differentiated strategy and consistent execution. This capital raise further strengthens our balance sheet, enabling us to invest in innovation, expand global access to lifesaving biopharmaceuticals, and advance our purpose of delivering affordable healthcare solutions that address pressing health inequities worldwide.'
According to the company, this fundraise, the first equity fundraise done by Biocon since its IPO in 2004, demonstrates the company's access to a diversified equity pool of capital.
The final order book was well diversified in terms of investor type across domestic mutual funds, insurance companies and foreign institutional investors. Some of the leading names who participated in the issue included SBI Mutual Fund, ICICI Prudential Mutual Fund, HDFC Life Insurance, Nippon India Mutual Fund, Mirae Asset Mutual Fund, Aditya Birla Mutual Fund, Franklin Templeton, SBI General Insurance, Government Pension Fund Global and Blackrock, the biotech firm further said.
The proceeds from the QIP would be utilised towards purchase of outstanding optionally convertible debentures issued by Biocon Subsidiary, Biocon Biologics Limited, from Goldman Sachs India AIF Scheme - 1 and Goldman Sachs India Alternative Investment Trust AIF Scheme – 2. Also, proceeds would be used for repayment, pre-payment or redemption, in full or in part, of certain outstanding financial instruments issued and/or borrowings availed by the company, and/or meeting other financial commitments of the company; and for general corporate purposes, as per the company.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

State Bank of India leads MF buys in July with ₹10,200-crore QIP wager
State Bank of India leads MF buys in July with ₹10,200-crore QIP wager

Business Standard

time3 days ago

  • Business Standard

State Bank of India leads MF buys in July with ₹10,200-crore QIP wager

Mutual funds (MFs)—flush with cash amid record inflows in July—invested heavily in the Rs 25,000-crore qualified institutional placement (QIP) of India's largest lender, State Bank of India (SBI). Fund managers acquired SBI shares worth Rs 10,200 crore last month, making the lender their biggest buy in July. According to Nuvama Alternative & Quantitative Research's (NAQR) estimates, SBI MF and HDFC MF deployed the highest amounts, at Rs 2,322 crore and Rs 1,500 crore, respectively. Quant MF and Nippon India MF bought close to Rs 1,200 crore worth of shares each. The largest-ever QIP in India had drawn bids worth nearly four times the shares on offer. Apart from domestic MFs, Life Insurance Corporation and about half a dozen foreign portfolio investors (FPIs) had participated in the QIP. Information technology (IT) giants Infosys and TCS, which were at the centre of last month's volatility, also witnessed heightened buying interest. Fund managers added Rs 9,400 crore worth of Infosys and TCS stocks into MF portfolios last month. HCL Technologies was also among the top 10 most bought stocks. The Nifty IT index suffered a 9 per cent decline in July, the highest among all sectoral indices. The index is down nearly 20 per cent in 2025, as lacklustre earnings, US tariff concerns, and staff layoffs amid weak demand outlook have dampened investor sentiment. Apart from IT, lenders SBI, newly listed HDB Financial, Axis Bank, Kotak Mahindra Bank, and ICICI Bank garnered MF investments of over Rs 2,000 crore. Despite the large investments, the cash holding in the equity MF schemes inched up last month. "After a brief phase of strong equity deployment by pure equity schemes—which had steadily reduced cash holdings—July saw a marginal uptick in the cash component. This was not due to limited deployment, but rather record inflows into mutual funds, prompting them to maintain slightly higher cash buffers. Cash and equivalents rose from Rs 1.82 trillion in June to Rs 1.85 trillion in July, lifting the proportion from 5.34 per cent to 5.46 per cent," the NAQR report said. Net inflows into equity schemes had scaled a record high in July, following a six-month period of subdued investor interest. Active equity schemes raked in a net Rs 42,702 crore last month, surpassing the previous high of Rs 41,156 crore in December 2024. Liquidity available with MFs also went up as a result of their move to trim allocation towards select stocks. Interglobe Aviation and Eternal witnessed net MF selling of Rs 2,400 crore and Rs 1,700 crore, respectively. HPCL, Hindalco Industries, HDFC AMC, ACC, and HDFC Bank were also among the most sold stocks.

SBI to raise ₹15,000 cr via Tier II bonds to replace maturing debt
SBI to raise ₹15,000 cr via Tier II bonds to replace maturing debt

Business Standard

time5 days ago

  • Business Standard

SBI to raise ₹15,000 cr via Tier II bonds to replace maturing debt

A senior SBI executive said the bank has approval from the board of directors to raise up to Rs 20,000 crore through debt capital in Fy26. Abhijit Lele Mumbai State Bank of India – the country's largest lender – plans to enter the debt capital market this financial year by issuing Tier-II bonds raising up to ₹15,000 crore to replace maturing paper and fresh issuance. A senior SBI executive said the bank has approval from the board of directors to raise up to ₹20,000 crore through debt capital in 2025-2026 (FY26). Out of this, additional Tier-I (AT1) is about ₹5,000 crore and Tier-II is about ₹15,000 crore. The timing, and coupon rate would be subject to market conditions, the executive added. Tier-II bonds worth ₹6,000 crore are maturing in FY26. SBI's Tier-II capital stood at ₹78,092 crore at the end of March this year, according to the red herring prospectus for raising equity capital from institutional investors in July. SBI has raised ₹25,000 crore of equity capital through Qualified Institutional Placement (QIP). Its capital adequacy ratio (CAR) stood at 14.63 per cent with common equity Tier-I of 11.1 per cent, additional Tier-I of 1.35 per cent, and Tier-II at 2.18 per cent at end of June. With the recent equity capital raise of ₹25,000 crore from institutional investors, the capital adequacy ratio will increase to 15.33 per cent. The capital requirements under Basel-III guidelines for banks in India indicate a minimum Tier-II level of 2.0 per cent in total CAR. The Tier-II instruments issued under Basel-III norms can be written down at the point of non-viability (PONV). According to rating agency CRISIL Ratings, the PONV trigger is a remote possibility in the Indian context. A robust regulatory and supervisory framework and the systemic importance of the banking sector are expected to ensure adequate and timely intervention by the Reserve Bank of India (RBI) to avoid a situation wherein a bank becomes non-viable. SBI's Tier-II capital base in percentage terms has seen moderation in the past three years with a ratio at 2.62 per cent for the year ended March 2023, 2.35 per cent in March 2024 and 2.14 per cent in March 2025.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store